Washington Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-625
| Closed | -$219K | – | 112 |
|
|
2025
Q4 | $219K | Hold |
625
| – | – | 0.18% | 105 |
|
|
2025
Q3 | $202K | Hold |
625
| – | – | 0.14% | 114 |
|
|
2025
Q2 | $243K | Hold |
625
| – | – | 0.18% | 111 |
|
|
2025
Q1 | $272K | Hold |
625
| – | – | 0.22% | 103 |
|
|
2024
Q4 | $231K | Hold |
625
| – | – | 0.18% | 106 |
|
|
2024
Q3 | $325K | Hold |
625
| – | – | 0.25% | 100 |
|
|
2024
Q2 | $339K | Hold |
625
| – | – | 0.29% | 94 |
|
|
2024
Q1 | $324K | Hold |
625
| – | – | 0.26% | 97 |
|
|
2023
Q4 | $295K | Hold |
625
| – | – | 0.25% | 98 |
|
|
2023
Q3 | $272K | Hold |
625
| – | – | 0.25% | 98 |
|
|
2023
Q2 | $278K | Hold |
625
| – | – | 0.24% | 100 |
|
|
2023
Q1 | $287K | Hold |
625
| – | – | 0.26% | 96 |
|
|
2022
Q4 | $321K | Hold |
625
| – | – | 0.3% | 94 |
|
|
2022
Q3 | $284K | Hold |
625
| – | – | 0.29% | 96 |
|
|
2022
Q2 | $302K | Hold |
625
| – | – | 0.29% | 93 |
|
|
2022
Q1 | $307K | Hold |
625
| – | – | 0.25% | 98 |
|
|
2021
Q4 | $290K | Hold |
625
| – | – | 0.23% | 98 |
|
|
2021
Q3 | $233K | Hold |
625
| – | – | 0.21% | 104 |
|
|
2021
Q2 | $239K | Hold |
625
| – | – | 0.29% | 102 |
|
|
2021
Q1 | $224K | Hold |
625
| – | – | 0.21% | 106 |
|
|
2020
Q4 | $201K | Buy |
+625
| New | +$192K | 0.19% | 103 |
|
|
2020
Q2 | – | Sell |
-1,250
| Closed | -$284K | – | 97 |
|
|
2020
Q1 | $284K | Hold |
1,250
| – | – | 0.36% | 82 |
|
|
2019
Q4 | $378K | Hold |
1,250
| – | – | 0.33% | 83 |
|
|
2019
Q3 | $300K | Hold |
1,250
| – | – | 0.29% | 86 |
|
|
2019
Q2 | $353K | Hold |
1,250
| – | – | 0.4% | 76 |
|
|
2019
Q1 | $359K | Hold |
1,250
| – | – | 0.41% | 82 |
|
|
2018
Q4 | $328K | Hold |
1,250
| – | – | 0.38% | 85 |
|
|
2018
Q3 | $343K | Sell |
1,250
-100
| -7% | -$26K | 0.33% | 92 |
|
|
2018
Q2 | $321K | Hold |
1,350
| – | – | 0.33% | 91 |
|
|
2018
Q1 | $297K | Hold |
1,350
| – | – | 0.3% | 93 |
|
|
2017
Q4 | $304K | Sell |
1,350
-397
| -23% | -$84.6K | 0.3% | 92 |
|
|
2017
Q3 | $332K | Hold |
1,747
| – | – | 0.35% | 84 |
|
|
2017
Q2 | $329K | Hold |
1,747
| – | – | 0.37% | 76 |
|
|
2017
Q1 | $289K | Hold |
1,747
| – | – | 0.34% | 80 |
|
|
2016
Q4 | $251K | Buy |
+1,747
| New | +$234K | 0.31% | 90 |
|
Other funds holding ELV
VCM
VPM
Washington Capital Management's ELV Position: Q1 2026 in Review
Washington Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 625 shares — an estimated $219K sold.
Washington Capital Management first reported a position in ELV in Q4 2016 and held it in 35 quarters. The position peaked at $378K in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Washington Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Washington Capital Management sold 625 Elevance Health shares in Q1 2026, an estimated $219K.
- Washington Capital Management first reported a position in Elevance Health in Q4 2016 and held it in 35 quarters.
- Washington Capital Management's Elevance Health position peaked at $378K in Q4 2019.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Washington Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.